Evidence map›Paper›PMID 34679711›Full record

ArticleAntioxidants (Basel, Switzerland)2021

Pseurotin D Induces Apoptosis through Targeting Redox Sensitive Pathways in Human Lymphoid Leukemia Cells.

Eva Mosejová, Rebeka Bosnjakovic, Lukáš Kubala, Ondřej Vašíček

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Eva MosejováInstitute of Biophysics of the Czech Academy of Sciences, 612 65 Brno, Czech Republic.
Rebeka BosnjakovicInstitute of Biophysics of the Czech Academy of Sciences, 612 65 Brno, Czech Republic.
Lukáš KubalaInstitute of Biophysics of the Czech Academy of Sciences, 612 65 Brno, Czech Republic.ORCID 0000-0002-7729-7338
Ondřej VašíčekInstitute of Biophysics of the Czech Academy of Sciences, 612 65 Brno, Czech Republic.ORCID 0000-0001-5892-0457
Czech Academy of Sciences, Institute of Biophysics · CZMasaryk University · CZ

Funding

Grantova agentura ceske republiky 17-18858SIBP CAS No.888811Operational Programme Research, Development and Education - "Preclinical Progression of New Organic Compounds with Targeted Biological Activity" CZ.02.1.01/0.0/0.0/16_025/0007381
6 · The paper itself

Abstract

Chronic lymphocytic leukemia (CLL) is the most prevalent lymphoid malignancy in many geographical regions of the world. Pseurotin D, a secondary metabolite of fungi, represents a group of bioactive natural products with a newly ascribed range of interesting biological activities. The purpose of this study was to bring new insights into the mechanism behind the effects of pseurotin D on MEC-1 cells as a representative CLL cell line, with a particular focus on selected signaling pathways important in the proliferation of cells and targeting mitochondrial metabolism. Our results showed that pseurotin D was able to significantly inhibit the proliferation of MEC-1 cells and arrested them in the G2/M cell cycle phase. In addition, pseurotin D was able to induce apoptosis. We found that all of these effects were associated with a change in mitochondrial membrane potential and the production of mitochondrial reactive oxygen species (ROS). We showed for the first time that pseurotin D suppresses MEC-1 cell proliferation and induces apoptotic cell death via induction of the collapse of the mitochondria respiratory chain and the ROS-related caspase pathway. Our results show the pseurotins family as promising compounds which could serve as a basis for the development of new compounds in the treatment of lymphoma.

Indexed as

apoptosislymphomamitochondrial activityproliferationpseurotin Dreactive oxygen species

Identifiers

PMID34679711
PMCPMC8533295
OpenAlexW3206596438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.